Global Assisted Reproductive Technology Market In Fertility Clinics 2018-2023


Report ID : RC-1910 Category : Healthcare Published Date : 18-Oct
Publisher : S-AND-P Pages : 99 Format : PDF
Infertility is a medical condition that affects both men and women. Generally, a couple is considered infertile when they are unable to conceive after a 12-month period of unprotected sexual intercourse. ART consists of a wide range of procedures that are used to treat infertility in men and women. These procedures are rendered to patients primarily in clinics, which treat infertility and are collectively referred to as fertility clinics.

The report covers the present scenario and the growth prospects of the global assisted reproductive technology market in fertility clinics for 2018-2023. To calculate the market size, the report considers the revenue generated from retail sales of ART solutions specifically to fertility clinics.

This report studies the global Assisted Reproductive Technology market, analyzes and researches the Assisted Reproductive Technology development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Merck KGaA
    CooperSurgical, Inc.
    Vitrolife AB.
    Hamilton Thorne, Inc.
    Nikon Corporation
    Nidacon International AB
    Laboratoire CCD
    Planer PLC
    Esco Micro Pte. Ltd. (Esco Group)

According to the report, one driver in the market is growing awareness about ART procedures. There is a notable increase in the awareness about ART procedures among women compared with the last decade. This encouraged a positive attitude and acceptance among women worldwide. The increase in awareness can be attributed to several factors such as the rise in education level among the female population and the rise in the number of working women. This had a significant influence on the demand for various ART procedures, especially in developed and developing countries such as the US, the UK, and China.

Further, the report states that one challenge in the market is limited insurance coverage and improper regulatory oversight. Infertility treatment is considered as a lifestyle procedure rather than serious medicine. Health insurance plans commonly, but not always, pay for services related to testing for infertility. For instance, in the US, which does not have any infertility coverage mandate, most insurance policies do not cover fertility and IVF service payment. Some insurances cover testing and treatment up to and including intrauterine insemination but do not cover IVF. Also, at times, the monitoring of IVF ovarian stimulation (blood and ultrasound tests) is covered but IVF codes are not covered. 
Global Assisted Reproductive Technology Market in Fertility Clinics Size, Status and Forecast 2023
1 Industry Overview of Assisted Reproductive Technology
    1.1 Assisted Reproductive Technology Market in Fertility Clinics Overview
        1.1.1 Assisted Reproductive Technology Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Assisted Reproductive Technology Market in Fertility Clinics Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Assisted Reproductive Technology Market in Fertility Clinics by Type
        1.3.1 by Technology
        1.3.2 by Procedures
    1.4 Assisted Reproductive Technology Market in Fertility Clinics by End Users/Application
        1.4.1 Fertility Clinics
        1.4.2 Hospitals

2 Global Assisted Reproductive Technology Competition Analysis by Players
    2.1 Assisted Reproductive Technology Market in Fertility Clinics Size (Value) by Players (2016 and 2018)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Merck KGaA
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Assisted Reproductive Technology Revenue (Value) (2012-2018)
        3.1.5 Recent Developments
    3.2 CooperSurgical, Inc.
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Assisted Reproductive Technology Revenue (Value) (2012-2018)
        3.2.5 Recent Developments
    3.3 Vitrolife AB.
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Assisted Reproductive Technology Revenue (Value) (2012-2018)
        3.3.5 Recent Developments
    3.4 Hamilton Thorne, Inc.
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Assisted Reproductive Technology Revenue (Value) (2012-2018)
        3.4.5 Recent Developments
    3.5 Nikon Corporation
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Assisted Reproductive Technology Revenue (Value) (2012-2018)
        3.5.5 Recent Developments
    3.6 Nidacon International AB
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Assisted Reproductive Technology Revenue (Value) (2012-2018)
        3.6.5 Recent Developments
    3.7 Laboratoire CCD
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Assisted Reproductive Technology Revenue (Value) (2012-2018)
        3.7.5 Recent Developments
    3.8 Planer PLC
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Assisted Reproductive Technology Revenue (Value) (2012-2018)
        3.8.5 Recent Developments
    3.9 Esco Micro Pte. Ltd. (Esco Group)
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Assisted Reproductive Technology Revenue (Value) (2012-2018)
        3.9.5 Recent Developments

4 Global Assisted Reproductive Technology Market in Fertility Clinics Size by Type and Application (2012-2018)
    4.1 Global Assisted Reproductive Technology Market in Fertility Clinics Size by Type (2012-2018)
    4.2 Global Assisted Reproductive Technology Market in Fertility Clinics Size by Application (2012-2018)
    4.3 Potential Application of Assisted Reproductive Technology in Future
    4.4 Top Consumer/End Users of Assisted Reproductive Technology

5 United States Assisted Reproductive Technology Development Status and Outlook
    5.1 United States Assisted Reproductive Technology Market in Fertility Clinics Size (2012-2018)
    5.2 United States Assisted Reproductive Technology Market in Fertility Clinics Size and Market Share by Players (2016 and 2018)

6 EU Assisted Reproductive Technology Development Status and Outlook
    6.1 EU Assisted Reproductive Technology Market in Fertility Clinics Size (2012-2018)
    6.2 EU Assisted Reproductive Technology Market in Fertility Clinics Size and Market Share by Players (2016 and 2018)

7 Japan Assisted Reproductive Technology Development Status and Outlook
    7.1 Japan Assisted Reproductive Technology Market in Fertility Clinics Size (2012-2018)
    7.2 Japan Assisted Reproductive Technology Market in Fertility Clinics Size and Market Share by Players (2016 and 2018)

8 China Assisted Reproductive Technology Development Status and Outlook
    8.1 China Assisted Reproductive Technology Market in Fertility Clinics Size (2012-2018)
    8.2 China Assisted Reproductive Technology Market in Fertility Clinics Size and Market Share by Players (2016 and 2018)

9 India Assisted Reproductive Technology Development Status and Outlook
    9.1 India Assisted Reproductive Technology Market in Fertility Clinics Size (2012-2018)
    9.2 India Assisted Reproductive Technology Market in Fertility Clinics Size and Market Share by Players (2016 and 2018)

10 Southeast Asia Assisted Reproductive Technology Development Status and Outlook
    10.1 Southeast Asia Assisted Reproductive Technology Market in Fertility Clinics Size (2012-2018)
    10.2 Southeast Asia Assisted Reproductive Technology Market in Fertility Clinics Size and Market Share by Players (2016 and 2018)

11 Market Forecast by Regions, Type and Application (2018-2023)
    11.1 Global Assisted Reproductive Technology Market in Fertility Clinics Size (Value) by Regions (2018-2023)
        11.1.1 United States Assisted Reproductive Technology Revenue and Growth Rate (2018-2023)
        11.1.2 EU Assisted Reproductive Technology Revenue and Growth Rate (2018-2023)
        11.1.3 Japan Assisted Reproductive Technology Revenue and Growth Rate (2018-2023)
        11.1.4 China Assisted Reproductive Technology Revenue and Growth Rate (2018-2023)
        11.1.5 India Assisted Reproductive Technology Revenue and Growth Rate (2018-2023)
        11.1.6 Southeast Asia Assisted Reproductive Technology Revenue and Growth Rate (2018-2023)
    11.2 Global Assisted Reproductive Technology Market in Fertility Clinics Size (Value) by Type (2018-2023)
    11.3 Global Assisted Reproductive Technology Market in Fertility Clinics Size by Application (2018-2023)

12 Assisted Reproductive Technology Market in Fertility Clinics Dynamics
    12.1 Assisted Reproductive Technology Market in Fertility Clinics Opportunities
    12.2 Assisted Reproductive Technology Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Assisted Reproductive Technology Market in Fertility Clinics Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Assisted Reproductive Technology Market in Fertility Clinics Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source

Sidebar Menu